These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17581302)

  • 1. D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69.
    Senogles SE
    Anticancer Drugs; 2007 Aug; 18(7):801-7. PubMed ID: 17581302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
    Hall DA; Strange PG
    Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.
    Ishida M; Mitsui T; Izawa M; Arita J
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):58-67. PubMed ID: 23701824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of growth of human small cell lung cancer by bromocriptine.
    Ishibashi M; Fujisawa M; Furue H; Maeda Y; Fukayama M; Yamaji T
    Cancer Res; 1994 Jul; 54(13):3442-6. PubMed ID: 8012964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical regulation of dopamine receptors in transfected 293 cells.
    Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
    Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture.
    Ishida M; Mitsui T; Yamakawa K; Sugiyama N; Takahashi W; Shimura H; Endo T; Kobayashi T; Arita J
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1529-37. PubMed ID: 17925456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
    Boundy VA; Pacheco MA; Guan W; Molinoff PB
    Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen inhibits D2S receptor-regulated Gi3 and Gs protein interactions to stimulate prolactin production and cell proliferation in lactotropic cells.
    Sengupta A; Sarkar DK
    J Endocrinol; 2012 Jul; 214(1):67-78. PubMed ID: 22573829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation.
    Vortherms TA; Watts VJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):221-7. PubMed ID: 14566008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, characterization and expression of the D2 dopamine receptor from the tilapia pituitary.
    Levavi-Sivan B; Aizen J; Avitan A
    Mol Cell Endocrinol; 2005 May; 236(1-2):17-30. PubMed ID: 15876479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine.
    Senogles SE
    Mol Pharmacol; 2000 Aug; 58(2):455-62. PubMed ID: 10908315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines.
    Tang L; Todd RD; Heller A; O'Malley KL
    J Pharmacol Exp Ther; 1994 Jan; 268(1):495-502. PubMed ID: 8301592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of dopamine D2 receptors in a novel cell line (SUP1).
    Ivins KJ; Luedtke RR; Artymyshyn RP; Molinoff PB
    Mol Pharmacol; 1991 Apr; 39(4):531-9. PubMed ID: 1708089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel report of apoptosis in human lung carcinoma cells using selective agonist of D2-like dopamine receptors: a new approach for the treatment of human non-small cell lung cancer.
    Sheikhpour M; Ahangari G; Sadeghizadeh M; Deezagi A
    Int J Immunopathol Pharmacol; 2013; 26(2):393-402. PubMed ID: 23755754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors.
    O'Hara CM; Uhland-Smith A; O'Malley KL; Todd RD
    J Pharmacol Exp Ther; 1996 Apr; 277(1):186-92. PubMed ID: 8613917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Membrane receptors and coupling proteins in adenohypophyseal cells].
    Cussac D; Caccavelli L; Pellegrini I; Audinot V; Jaquet P; Enjalbert A
    C R Seances Soc Biol Fil; 1993; 187(1):14-23. PubMed ID: 8242419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the alternatively spliced insert region of the D2L dopamine receptor by epitope substitution.
    Kendall RT; Senogles SE
    Neurosci Lett; 2006 Jan; 393(2-3):155-9. PubMed ID: 16226376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
    Taves J; Rastedt D; Canine J; Mork D; Wallert MA; Provost JJ
    Arch Biochem Biophys; 2008 Sep; 477(1):60-6. PubMed ID: 18539131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.